GURU.Markets stock price, segment price, and overall market index valuation
The company's share price InterCure Ltd.
InterCure is a leading medical cannabis producer and distributor in Israel. Its share price reflects the growth of this market, as well as regulatory changes and the company's export potential.
Share prices of companies in the market segment - Narco farm
InterCure is a leading Israeli company in the medical cannabis industry, controlling the entire chain from cultivation to retail sales in pharmacies under the Canndoc brand. We've classified it in the "Narco Farm" segment. The chart below shows the overall dynamics of the legal cannabis sector, which is highly dependent on changes in legislation and market conditions.
Broad Market Index - GURU.Markets
InterCure is a leading Israeli company producing and selling medical cannabis under the Canndoc brand. As an industry pioneer, it is included in our GURU.Markets index. The chart below reflects the overall stock market performance. Compare it to InterCure's stock to assess the state of this volatile sector.
Change in the price of a company, segment, and market as a whole per day
INCR - Daily change in the company's share price InterCure Ltd.
For InterCure Ltd., an Israeli medical cannabis company, daily volatility reflects sensitivity to regulatory developments in Europe and globally. This metric is an important element of analysis in this specific and dynamic industry.
Daily change in the price of a set of shares in a market segment - Narco farm
For InterCure Ltd., an Israeli medical cannabis company, daily volatility reflects sensitivity to regulatory developments in Europe and globally. This metric is an important element of analysis in this specific and dynamic industry.
Daily change in the price of a broad market stock, index - GURU.Markets
InterCure is one of the leading medical cannabis producers and distributors in Israel. Its shares reflect both the industry's rapid growth and regulatory risks. The sector's dynamics add a unique and volatile element to the overall market landscape.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization InterCure Ltd.
The year-over-year performance of InterCure Ltd., operating under the Canndoc brand, reflects its leadership in the Israeli medical cannabis market. Its market capitalization growth over the past 12 months is driven by an increasing number of patients, its vertical integration (from cultivation to dispensaries), and success in exporting its products to other countries, such as Germany.
Annual dynamics of market capitalization of the market segment - Narco farm
InterCure Ltd. is one of the leading medical cannabis companies in Israel. Its performance is heavily dependent on the country's regulatory policies and its efforts to expand into international markets. The chart below shows how these specific factors influence its volatile performance.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
InterCure, a cannabis production and sales company, lives in a world of regulatory news, not economic cycles. Its stock price (ADR) is driven not by GDP, but by steps toward legalization in Europe and its own struggle for profitability. Its chart is a story of high hopes and constant disappointments.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization InterCure Ltd.
InterCure is a leading company in the Israeli medical cannabis market. Its monthly growth reflects both domestic sales growth and success in exporting to Europe. Legislative changes and quarterly revenue growth reports are the main drivers.
Monthly dynamics of market capitalization of the market segment - Narco farm
InterCure Ltd. is one of the leading and fastest-growing medical cannabis companies in Israel, also expanding internationally. Its sector dynamics, shown in the chart, are volatile. Against this backdrop, one can see how its pharmaceutical approach and strong Canndoc brand help it lead the market.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
InterCure is a leading company in the Israeli medical cannabis market. Its stock price is driven by news of legalization, sales, and expansion into European markets. The chart shows the dynamics, which are determined entirely by the specifics of the cannabis industry, rather than general market trends.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization InterCure Ltd.
InterCure, one of Israel's leading medical cannabis producers and distributors, has seen its weekly stock price reflect regulatory changes and market growth. Its expansion into Europe and sales data are shaping short-term trends in this growing industry.
Weekly dynamics of market capitalization of the market segment - Narco farm
InterCure is a leading medical cannabis company in Israel. Its business is dependent on legislation and demand. This chart shows how its performance compares to the global cannabis sector, allowing you to assess the impact of regional factors and its market share against the backdrop of overall industry trends.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
InterCure is a cannabis company. The sector is highly volatile and vulnerable to regulatory changes. The chart shows how INCR shares move at their own pace, often ignoring broader market trends and reacting to industry-specific news.
Market capitalization of the company, segment and market as a whole
INCR - Market capitalization of the company InterCure Ltd.
InterCure's market capitalization is a financial map of the Israeli medical cannabis market. The chart of this leading company, operating under the Canndoc brand, reflects not only domestic demand but also its export ambitions. Its dynamics are a barometer of regulatory changes and competition in one of the most developed medical cannabis markets in the world.
INCR - Share of the company's market capitalization InterCure Ltd. within the market segment - Narco farm
InterCure's market share in the cannabis sector reflects its dominant position in the Israeli medical cannabis market under the Canndoc brand. Its market share reflects its production capacity, pharmacy network, and ability to expand into emerging European markets.
Market capitalization of the market segment - Narco farm
InterCure is a leading medical cannabis company in Israel. The chart below shows the total market capitalization of this young and volatile sector. Its dynamics reflect legislative changes and the challenging path to globalization.
Market capitalization of all companies included in a broad market index - GURU.Markets
InterCure is a leading company in the Israeli medical cannabis market. Its market capitalization reflects its dominant position and the growth of the legal market in the country and Europe. The chart below shows the economic weight of the country's leading cannabis companies.
Book value capitalization of the company, segment and market as a whole
INCR - Book value capitalization of the company InterCure Ltd.
The book value of InterCure, Israel's leading medical cannabis producer, is derived from its greenhouses, dispensaries, and processing facilities. The chart below shows how the company is building its vertically integrated empire. Growth in this chart represents the expansion of its physical assets, from seed to sales.
INCR - Share of the company's book capitalization InterCure Ltd. within the market segment - Narco farm
InterCure is a leading company in the Israeli medical cannabis market. Its business is vertically integrated, from greenhouses to dispensaries. The asset share chart directly reflects the scale of its physical infrastructure, from seed to retail, which is a key advantage.
Market segment balance sheet capitalization - Narco farm
InterCure is a leading company in the medical cannabis industry in Israel. Its business is highly capital-intensive, including greenhouses, processing plants, and a network of pharmacies. This chart illustrates how dependent the entire cannabis industry is on ownership of the entire chain—from cultivation to sales.
Book value of all companies included in the broad market index - GURU.Markets
InterCure is a vertically integrated medical cannabis producer in Israel, spanning from cultivation to pharmacy operations. Its book value reflects its physical assets (greenhouses, laboratories, pharmacies) and its dominant position in one of the most developed medical cannabis markets in the world.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - InterCure Ltd.
InterCure is the leading medical cannabis production and sales company in Israel. Its balance sheet includes greenhouses and production facilities. Its market capitalization reflects its dominant position in the domestic market and its export potential. The chart is a barometer of sentiment in the Israeli cannabis industry.
Market to book capitalization ratio in a market segment - Narco farm
InterCure is a leading company in the Israeli medical cannabis market. It is vertically integrated, from cultivation to dispensaries. The chart shows how the market values its dominant position in the regulated market and its physical assets (greenhouses, production lines).
Market to book capitalization ratio for the market as a whole
InterCure is the leading medical cannabis production and sales company in Israel. The chart shows how the market values this regulated market leader. Its market capitalization reflects its market share, brand strength, and production capacity, as well as expectations regarding further legalization and exports.
Debts of the company, segment and market as a whole
INCR - Company debts InterCure Ltd.
InterCure is one of the leading companies producing and selling medical cannabis in Israel and Europe. Its debt load reflects investments in expanding its production capacity (greenhouses) and building a distribution network to meet growing demand, as this chart illustrates.
Market segment debts - Narco farm
InterCure is one of the leading companies in the Israeli medical cannabis market, expanding internationally. This young sector requires significant investment in cultivation, production, and distribution. This chart illustrates the financial realities of this emerging industry, where companies are raising capital to quickly capture market share.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio InterCure Ltd.
InterCure is one of the leading companies in the medical cannabis market in Israel and beyond. Rapid growth in this emerging industry often requires significant investment in production and distribution. This chart shows how aggressively the company uses debt to finance its expansion, a key risk factor.
Market segment debt to market segment book capitalization - Narco farm
InterCure, a medical cannabis producer and distributor, operates in a highly regulated and rapidly growing industry. This chart shows the sector's debt load. It allows one to assess how aggressively this Israeli company, a leader in its market, is using capital to expand production and international expansion compared to its competitors.
Debt to book value of all companies in the market
InterCure is one of the leading companies in the Israeli medical cannabis market. The rapidly growing and strictly regulated industry requires investment in production and distribution. The chart shows how their debt load for scaling the business compares to more traditional industries.
P/E of the company, segment and market as a whole
P/E - InterCure Ltd.
This chart shows the valuation of InterCure, one of the leading medical cannabis companies in Israel. The valuation reflects investor expectations regarding the growth of the legal cannabis market, both domestic and export, and the company's ability to maintain its leading position.
P/E of the market segment - Narco farm
This chart shows the average valuation for companies in the medical cannabis industry, like InterCure. This metric is highly volatile and reflects investor sentiment on the prospects for legalization and market growth. It serves as a barometer for the entire sector, allowing one to understand how InterCure compares to its peers.
P/E of the market as a whole
InterCure is a leading Israeli medical cannabis company. It is one of the few profitable companies in the industry, thanks to its dominant position in the local market and exports. This chart reflects the mood in the cannabis market, comparing InterCure's stable and profitable model with more speculative and unprofitable companies in North America.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company InterCure Ltd.
InterCure is a leading Israeli company producing and selling medical cannabis under the Canndoc brand. Future growth depends on expansion into international markets and regulatory changes. This chart reflects investor expectations regarding the growth of the European medical cannabis market and the company's ability to become a key supplier in the region.
%20P%2FE%20InterCure%20Ltd.&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-InterCure-Ltd.&v=1772641089350 "Chart of the company's future (projected) P/E InterCure Ltd.")
Future (projected) P/E of the market segment - Narco farm
InterCure is a leading company in the production and sale of medical cannabis in Israel under the Canndoc brand. The company is also actively expanding into international markets. This chart reflects sector expectations, allowing one to assess the market's perception of the prospects for this Israeli leader in the global cannabis industry.
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20Narco%20farm&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-Narco-farm&v=1772641089366 "Future (projected) P/E graph of the market segment - Narco farm")
Future (projected) P/E of the market as a whole
InterCure is a leading Israeli company producing and selling medical cannabis under the Canndoc brand. Their success depends on legislation and growing demand for their products. This chart of general expectations reflects investor sentiment toward emerging industries. Market optimism and the global trend toward cannabis legalization create a favorable backdrop for InterCure's business expansion.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772641089377 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit InterCure Ltd.
InterCure is a leading medical cannabis company in Israel under the Canndoc brand. This chart reflects growth in this regulated market. The company's profits depend on sales volumes in pharmacies, expansion of production capacity, and potential exports to other countries as legalization progresses.
Profit of companies in the market segment - Narco farm
Klotho Neurosciences Inc. is an early-stage biotech company likely focused on neurodegenerative diseases. Its financial metrics reflect R&D expenses. This chart provides a general overview for a sector where profitability is a distant goal and current valuation is determined by the potential of its scientific platform.
Overall market profit
InterCure is a leading medical cannabis company in Israel, operating under the Canndoc brand. The company is also expanding its operations in Europe. Its growth depends on the regulatory environment, the development of medical cannabis, and its ability to compete in the emerging global market.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company InterCure Ltd.
InterCure is a leading Israeli company producing and selling medical cannabis under the Canndoc brand. Its profit forecast hinges on the growth of the Israeli market and successful expansion into international markets such as Germany. This chart reflects analyst expectations for the future of the legal cannabis market and InterCure's leadership.
%20profit%20of%20the%20company%20InterCure%20Ltd.&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-InterCure-Ltd.&v=1772641089532 "Graph of future (projected) profit of the company InterCure Ltd.")
Future (predicted) profit of companies in the market segment - Narco farm
InterCure is a leading Israeli company producing and distributing medical cannabis under the Canndoc brand. The company is actively expanding its presence in Europe. This chart shows profitability forecasts for the cannabis sector. It reflects how legalization and the growth of medical cannabis use worldwide are creating new markets for leaders like InterCure.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20Narco%20farm&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-Narco-farm&v=1772641089557 "Graph of future (predicted) profits of companies in a market segment - Narco farm")
Future (predicted) profit of the market as a whole
InterCure is one of the leading companies in the Israeli medical cannabis market. Its growth depends on the regulatory environment and the expansion of both the medical and recreational markets. This graph of overall revenue projections helps assess the overall state of consumer spending, which may impact demand for the company's products, particularly in the recreational segment.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772641089565 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - InterCure Ltd.
InterCure is a leading Israeli medical cannabis company under the Canndoc brand. It controls a significant market share in Israel and exports products to other countries. The chart shows how investors assess its dominance and growth potential as medical cannabis becomes legalized and becomes more widespread worldwide.
P/S market segment - Narco farm
InterCure Ltd. is one of the leading and fastest-growing medical cannabis companies outside of North America. It produces and distributes pharmaceutical-grade products. This chart shows the average valuation in the sector, allowing one to assess how the market values InterCure's international presence and vertical integration.
P/S of the market as a whole
InterCure is a leading company in the Israeli medical cannabis market, cultivating, producing, and distributing products. The company is also expanding into international markets. This chart reflects overall market revenue estimates, allowing investors to compare how the company's revenue is valued by investors as a leader in one of the most developed cannabis markets.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company InterCure Ltd.
InterCure is a leading Israeli company in the medical cannabis industry, operating under the Canndoc brand. This chart shows how investors estimate the company's future revenue. It reflects expectations for growth in the Israeli and European medical cannabis markets, as well as the company's ability to scale production and sales.
%20P%2FS%20InterCure%20Ltd.&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-InterCure-Ltd.&v=1772641089616 "The graph of the company's future (projected) P/S InterCure Ltd.")
Future (projected) P/S of the market segment - Narco farm
InterCure is a leading Israeli company in the medical cannabis industry, operating under the Canndoc brand. It cultivates, produces, and distributes pharmaceutical-grade products. The chart shows how the market estimates InterCure's future revenue, reflecting its leading position in the Israeli market and its export potential.
%20P%2FS%20market%20segment%20graph%20-%20Narco%20farm&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-Narco-farm&v=1772641089644 "Future (projected) P/S market segment graph - Narco farm")
Future (projected) P/S of the market as a whole
Expectations for future economic revenue reflect the legalization and growth of the medical cannabis market. InterCure, one of the leading companies in this industry in Israel and Europe, is at the forefront of this process. Their sales growth and expansion into new markets demonstrate how this emerging industry is becoming part of the global healthcare system.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772641089649 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales InterCure Ltd.
InterCure is a leading company in the Israeli medical cannabis market, operating under the Canndoc brand. The company generates revenue from the cultivation, production, and sale of its pharmaceutical products to patients in pharmacies. This chart reflects the growth of the legalized cannabis market and the company's leading position within it.
Sales of companies in the market segment - Narco farm
InterCure is Israel's leading producer and distributor of medical cannabis under the Canndoc brand. This chart shows the overall revenue of the cannabis sector. It reflects the growth of legal medical cannabis markets worldwide and companies' efforts to establish pharmaceutical-grade quality standards for their products.
Overall market sales
InterCure is a leading Israeli company in the medical cannabis industry. It cultivates, produces, and distributes products internationally. The company's growth depends on the legalization of cannabis and increased demand for its products. This general economic trend is less important than regulatory changes and specific trends in its rapidly growing industry.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company InterCure Ltd.
InterCure is a leading Israeli company producing and selling medical cannabis under the Canndoc brand. The company's growth depends on expansion in both domestic and international markets. The chart shows analyst revenue forecasts, reflecting their expectations for legalization and growth of the medical cannabis market in Europe and other regions.
%20sales%20of%20the%20company%20InterCure%20Ltd.&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-InterCure-Ltd.&v=1772641089699 "Schedule of future (projected) sales of the company InterCure Ltd.")
Future (projected) sales of companies in the market segment - Narco farm
InterCure is a leading medical cannabis production and sales company in Israel, operating under the Canndoc brand. The company is actively expanding its presence in Europe. This chart shows projected revenues for the entire cannabis pharmaceutical sector, reflecting expectations for growth in the legalized market and demand for medical marijuana.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20Narco%20farm&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-Narco-farm&v=1772641089709 "Schedule of future (projected) sales of companies in the market segment - Narco farm")
Future (projected) sales of the market as a whole
InterCure is a leading Israeli company producing and selling medical cannabis under the Canndoc brand. Its growth depends on market expansion in Israel and exports to other countries. This overall economic activity schedule has less of an impact on its business than regulatory changes and the development of the medical cannabis market.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772641089726 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality InterCure Ltd.
InterCure is one of the leading companies in the medical cannabis market in Israel and Europe. This metric reflects the effectiveness of its vertically integrated model. It shows what percentage of revenue from sales of its products "from seed to dispensary" the company converts into net profit, operating in a strictly regulated market.
Market segment marginality - Narco farm
InterCure is a leading Israeli medical cannabis company. Profitability in this highly regulated industry depends on the efficiency of cultivation, production, and distribution. This metric demonstrates the company's success in one of the most developed medical cannabis markets in the world.
Market marginality as a whole
InterCure is a leading Israeli company producing medical cannabis under the Canndoc brand. They control the entire supply chain, from cultivation to dispensary sales. Their growth depends on regulations and demand for medical cannabis. The overall profitability of their traditional business is less important to them than legislative changes and medical trends.
Employees in the company, segment and market as a whole
Number of employees in the company InterCure Ltd.
InterCure is a leading company producing and selling medical cannabis in Israel under the Canndoc brand. This chart reflects its operational scale. The growth in staff in greenhouses, production, and the pharmacy chain is directly related to the expansion of production capacity and distribution to meet growing demand.
Share of the company's employees InterCure Ltd. within the market segment - Narco farm
InterCure is Israel's leading medical cannabis company. This chart shows its share of the total workforce in the country's medical cannabis industry. It demonstrates its leading role as an employer of agronomists, pharmacists, and distribution specialists in this highly regulated sector.
Number of employees in the market segment - Narco farm
InterCure Ltd. is one of the leading companies in the production and distribution of medical cannabis in Israel and international markets. This chart shows overall employment in the pharmaceutical sector. It illustrates the growth and legalization of the medical cannabis industry, where InterCure strives to achieve a leading position through product quality.
Number of employees in the market as a whole
InterCure is a leading Israeli company producing and distributing medical cannabis under the Canndoc brand. It is one of the fastest-growing companies in this industry outside of North America. This employment chart also reflects the emergence of new legalized industries, which are creating thousands of jobs in agriculture, manufacturing, distribution, and retail.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company InterCure Ltd. (INCR)
InterCure Ltd. is a leading medical cannabis company in Israel, engaged in production and distribution. This chart helps understand the business structure. The moderate capitalization per employee reflects the combination of R&D and brand equity (high valuation) with the need for staff to grow, process, and sell products in pharmacies.
%20of%20the%20company%20InterCure%20Ltd.%20(INCR)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-InterCure-Ltd.-INCR&v=1772641089926 "Chart of market capitalization per employee (in thousands of dollars) of the company InterCure Ltd. (INCR)")
Market capitalization per employee (in thousands of dollars) in the market segment - Narco farm
InterCure is a leading company in the Israeli medical cannabis market, operating under the Canndoc brand. Their business encompasses cultivation, production, and distribution. This metric reflects the efficiency of their vertically integrated model. A comparison with peers will demonstrate how optimal their production and distribution processes are per employee.
%20by%20market%20segment%20-%20Narco%20farm&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-Narco-farm&v=1772641089946 "Market capitalization per employee (in thousands of dollars) by market segment - Narco farm")
Market capitalization per employee (in thousands of dollars) for the overall market
InterCure Ltd. is one of the leading companies producing and selling medical cannabis in Israel and internationally. Its valuation reflects both its production capacity and the strength of its brand and distribution network. The per-employee valuation illustrates the development of a new industry that combines agriculture, pharmaceuticals, and retail.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772641089959 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company InterCure Ltd. (INCR)
InterCure (INCR) is the leading medical cannabis company in Israel (brand Canndoc). They control the entire supply chain, from cultivation to distribution through their own dispensaries. This chart shows how effectively this vertically integrated model generates net profit per employee.
%20Chart%20InterCure%20Ltd.%20(INCR)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-InterCure-Ltd.-INCR&v=1772641089974 "Company Profit Per Employee (in thousands of dollars) Chart InterCure Ltd. (INCR)")
Profit per employee (in thousands of dollars) in the market segment - Narco farm
InterCure is the leading medical cannabis production and sales company in Israel. This chart is a benchmark for the emerging industry. INCR's profitability per employee depends on the efficiency of their cultivation and processing processes, as well as the pricing of their products in the medical and, potentially, recreational markets. It's an agribusiness with a pharmaceutical focus.
%20in%20the%20market%20segment%20-%20Narco%20farm&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-Narco-farm&v=1772641089982 "Chart of profit per employee (in thousands of dollars) in the market segment - Narco farm")
Profit per employee (in thousands of dollars) for the market as a whole
InterCure (INCR) is a leading medical cannabis production and distribution company in Israel, also expanding in Europe. It is a vertically integrated "drug-pharma" business. This metric reflects their profitability: from the agronomists who grow the product to the pharmacists in the pharmacies who generate the final profit.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772641090003 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee InterCure Ltd. (INCR)
For InterCure, a leading Israeli company producing and selling medical cannabis, this chart reflects the growth of the legal market. The growth in revenue per employee indicates an increase in production volumes and sales through its pharmacy network, which is an indicator of business maturity.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-InterCure-Ltd.-INCR&v=1772641090013 "Sales chart per company employee InterCure Ltd. (INCR)")
Sales per employee in the market segment - Narco farm
InterCure is an Israeli company and a leader in the medical cannabis market (under the Canndoc brand). This metric reflects the average revenue per employee in the segment. It allows one to assess how productive the company is in growing, processing, and selling its products compared to other producers in this regulated industry.
Sales per employee for the market as a whole
InterCure (INCR) is a leading Israeli company producing and distributing medical cannabis (under the Canndoc brand). This metric reflects the effectiveness of their vertically integrated model. The growth in revenue per employee (agronomist, pharmacist) indicates that the company is successfully expanding production and sales of its products in a growing market.
Short shares by company, segment and market as a whole
Shares shorted by company InterCure Ltd. (INCR)
InterCure is a leading medical cannabis producer in Israel. The company is also exploring international markets. This chart reflects investor bets that the Israeli market is too small and the European market too challenging to grow quickly, while cannabis prices worldwide are under pressure due to oversupply.
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-InterCure-Ltd.-INCR&v=1772641090053 "Short Shares Chart for the Company InterCure Ltd. (INCR)")
Shares shorted by market segment - Narco farm
InterCure (INCR) is one of the leading companies producing and selling medical cannabis in Israel (brand Canndoc). This chart shows the overall short position in the cannabis sector. It reflects investor pessimism about the entire industry due to regulatory barriers, oversupply, and chronic unprofitability.
Shares shorted by the overall market
InterCure is a player in the cannabis market, a sector already plagued by regulatory issues and a lack of profitability. When this overall pessimism rises, investors completely lose their appetite for risk. They sell off unprofitable, speculative sectors en masse, and INCR is no exception.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator InterCure Ltd. (INCR)
This oscillator for InterCure (Canndoc) is an indicator of sentiment in the Israeli medical cannabis market. The company is one of the leaders in this sector. News about loosening regulations, increasing numbers of patients receiving prescriptions, or successes in exporting to Europe trigger "overheating" (above 70). Increasing competition or licensing delays lead to "oversold" (below 30).
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-InterCure-Ltd.-INCR&v=1772641090090 "RSI 14 indicator chart for the company's stock InterCure Ltd. (INCR)")
RSI 14 Market Segment - Narco farm
InterCure (INCR) (Canndoc) is a pioneer of Israeli cannabis. They are the market leader in medical cannabis in Israel. The "Narco farm" (cannabis) sector is the king of the hype. RSI_14_Seg shows the "temperature" of the entire industry. It helps us understand whether INCR's growth is their niche or the general hype.
RSI 14 for the overall market
InterCure (INCR), an Israeli cannabis company. This chart is an indicator of risk appetite. In euphoria, investors are willing to invest in the hyped sector. In panic, funding for cannabis operators dries up, and geopolitical risks (the Middle East) add a "second tier" of fear.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast INCR (InterCure Ltd.)
InterCure (brand name Canndoc) is a leading Israeli medical cannabis company, controlling a significant market share (pharmacies, distribution) in Israel and exporting to Europe. This chart shows the average target price from analysts assessing the growth of this regulated market.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-INCR-InterCure-Ltd.&v=1772641090143 "A chart showing analyst consensus forecasts for the expected stock price. INCR (InterCure Ltd.)")
The difference between the consensus estimate and the actual stock price INCR (InterCure Ltd.)
INCR - InterCure (Canndoc) is a leading Israeli medical cannabis production and distribution company actively expanding in Europe. This chart shows the gap between the market valuation and analyst target price. It reveals whether experts believe in the growth of the European market and their dominant position in Israel.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-INCR-InterCure-Ltd.&v=1772641090166 "A chart showing the difference between the consensus forecast and the actual stock price. INCR (InterCure Ltd.)")
Analyst consensus forecast for stock prices by market segment - Narco farm
InterCure (INCR) is a leading medical cannabis production and distribution company in Israel, operating under the Canndoc brand. This chart shows analysts' overall expectations for the sector, reflecting whether experts believe the mature, yet regulated, Israeli market will see sustained growth.
Analysts' consensus forecast for the overall market share price
InterCure is a leading Israeli company producing and selling medical cannabis (under the Canndoc brand). This chart shows overall risk appetite. For InterCure, which operates in the cannabis sector, which is dependent on legalization (especially in Europe), overall market optimism is important, but regulatory news carries far more weight than general sentiment.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index InterCure Ltd.
InterCure (INCR) is the king of Israeli cannabis. They are the leader (under the Canndoc brand) in the Israeli medical cannabis market and actively export their products to Europe (Germany). This chart represents their international cannabis market share. It measures their dominance in their home (regulated) market and their success as a premium European exporter.
AKIMA Market Segment Index - Narco farm
InterCure is a leading medical cannabis production and distribution company in Israel (under the Canndoc brand), which is also expanding into Europe. This chart shows the average index for the pharma/narcotics sector. It allows investors to assess how InterCure performs relative to the regulated industry average.
The AKIM Index for the overall market
InterCure is a leading medical cannabis company in Israel, expanding into international (pharmaceutical-standard) markets. This chart, reflecting the market average, provides context. It helps assess how this growth story in the regulated sector compares to overall macroeconomic trends and geopolitical risks.
